Wave Life Sciences WVE Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Wave Life Sciences’s reported figures.
The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Wave Life Sciences's free cash flow?
- Wave Life Sciences (WVE) reported free cash flow of -$59.99M in Q1 2026.
- How has Wave Life Sciences's free cash flow changed year-over-year?
- Wave Life Sciences's free cash flow increased by 5.1% year-over-year, from -$63.2M to -$59.99M.
- What is the long-term trend for Wave Life Sciences's free cash flow?
- Over 3 years (2021 to 2025), Wave Life Sciences's free cash flow has grown at a 28.1% compound annual growth rate (CAGR), from -$89.55M to -$188.21M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.